84 related articles for article (PubMed ID: 14713249)
21. Evidence against the adrenoleukodystrophy-related gene acting as a modifier of X-adrenoleukodystrophy.
Holzinger A; Mayerhofer PU; Maier EM; Roscher AA; Berger J
Adv Exp Med Biol; 2003; 544():95-6. PubMed ID: 14713219
[No Abstract] [Full Text] [Related]
22. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
23. [SREBP controls cholesterol homeostasis].
Sato R; Sakai J
Seikagaku; 2004 Jun; 76(6):503-8. PubMed ID: 15287495
[No Abstract] [Full Text] [Related]
24. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
McGuinness MC; Zhang HP; Smith KD
Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
[TBL] [Abstract][Full Text] [Related]
25. Phenylbutyrate up-regulates the adrenoleukodystrophy-related gene as a nonclassical peroxisome proliferator.
Gondcaille C; Depreter M; Fourcade S; Lecca MR; Leclercq S; Martin PG; Pineau T; Cadepond F; ElEtr M; Bertrand N; Beley A; Duclos S; De Craemer D; Roels F; Savary S; Bugaut M
J Cell Biol; 2005 Apr; 169(1):93-104. PubMed ID: 15809314
[TBL] [Abstract][Full Text] [Related]
26. X-linked adrenoleukodystrophy: improved prenatal diagnosis using both biochemical and immunological methods.
Wanders RJ; Mooyer PW; Dekker C; Vreken P
J Inherit Metab Dis; 1998 Jun; 21(3):285-7. PubMed ID: 9686376
[No Abstract] [Full Text] [Related]
27. Cholesterol signaling at the endoplasmic reticulum occurs in npc1(-/-) but not in npc1(-/-), LDLR(-/-) mice.
Erickson RP; Kiela M; Garver WS; Krishnan K; Heidenreich RA
Biochem Biophys Res Commun; 2001 Jun; 284(2):326-30. PubMed ID: 11394880
[TBL] [Abstract][Full Text] [Related]
28. [X-linked adrenoleukodystrophy (ALD)].
Imamura A; Suzuki Y
Nihon Rinsho; 2004 Jan; 62 Suppl():389-92. PubMed ID: 15011392
[No Abstract] [Full Text] [Related]
29. A happier sequel to Lorenzo's Oil?
Wanders RJ
Nat Med; 1998 Nov; 4(11):1245-6. PubMed ID: 9809546
[No Abstract] [Full Text] [Related]
30. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.
Horton JD; Goldstein JL; Brown MS
J Clin Invest; 2002 May; 109(9):1125-31. PubMed ID: 11994399
[No Abstract] [Full Text] [Related]
31. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease.
Kawaguchi K; Morita M
Biomed Res Int; 2016; 2016():6786245. PubMed ID: 27766264
[TBL] [Abstract][Full Text] [Related]
32. Valproic acid induces antioxidant effects in X-linked adrenoleukodystrophy.
Fourcade S; Ruiz M; Guilera C; Hahnen E; Brichta L; Naudi A; Portero-Otín M; Dacremont G; Cartier N; Wanders R; Kemp S; Mandel JL; Wirth B; Pamplona R; Aubourg P; Pujol A
Hum Mol Genet; 2010 May; 19(10):2005-14. PubMed ID: 20179078
[TBL] [Abstract][Full Text] [Related]
33. X-linked adrenoleukodystrophy phenotype is independent of ABCD2 genotype.
Maier EM; Mayerhofer PU; Asheuer M; Köhler W; Rothe M; Muntau AC; Roscher AA; Holzinger A; Aubourg P; Berger J
Biochem Biophys Res Commun; 2008 Dec; 377(1):176-80. PubMed ID: 18834860
[TBL] [Abstract][Full Text] [Related]
34. Poloxamer 407 (P-407)-mediated reduction in the gene expression of ATP-binding-cassette transporter A1 may contribute to increased cholesterol in peripheral tissues of P-407-treated rats.
Johnston TP; Jaye M; Webb CL; Krawiec JA; Alom-Ruiz SP; Sachs-Barrable K; Wasan KM
Eur J Pharmacol; 2006 May; 536(3):232-40. PubMed ID: 16603153
[TBL] [Abstract][Full Text] [Related]
35. Suppression of peroxisomal membrane protein defects by peroxisomal ATP binding cassette (ABC) proteins.
Braiterman LT; Zheng S; Watkins PA; Geraghty MT; Johnson G; McGuinness MC; Moser AB; Smith KD
Hum Mol Genet; 1998 Feb; 7(2):239-47. PubMed ID: 9425230
[TBL] [Abstract][Full Text] [Related]
36. X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects.
Kemp S; Berger J; Aubourg P
Biochim Biophys Acta; 2012 Sep; 1822(9):1465-74. PubMed ID: 22483867
[TBL] [Abstract][Full Text] [Related]
37. X-linked adrenoleukodystrophy.
Aubourg P; Mandel JL
Ann N Y Acad Sci; 1996 Dec; 804():461-76. PubMed ID: 8993565
[No Abstract] [Full Text] [Related]
38. Role of family D ATP-binding cassette transporters (ABCD) in cancer.
Hlaváč V; Souček P
Biochem Soc Trans; 2015 Oct; 43(5):937-42. PubMed ID: 26517907
[TBL] [Abstract][Full Text] [Related]
39. A closer look at the cholesterol sensor.
Gimpl G; Burger K; Fahrenholz F
Trends Biochem Sci; 2002 Dec; 27(12):596-9. PubMed ID: 12468222
[No Abstract] [Full Text] [Related]
40. Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice.
Yamada T; Shinnoh N; Taniwaki T; Ohyagi Y; Asahara H; Horiuchi ; Kira J
J Inherit Metab Dis; 2000 Sep; 23(6):607-14. PubMed ID: 11032335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
